B.Riley analyst Madison El-Saadi reiterated a Buy rating and $11.00 price target on WAVE Life Sciences (NASDAQ: WVE).The analyst comments ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

WAVE Life Sciences (WVE) no longer intends to offers ordinary sharesSeptember 24, 2024 5:23 PM Form 424B5 Wave Life Sciences Ltd. September 24, 2024 5:16 PM Form 424B3 Wave Life Sciences Ltd. September 24, 2024 5:14 PM After-hours movers: KB Home, Progress Software, Worthington Industries and moreSeptember 24, 2024 4:34 PM WAVE Life Sciences (WVE) Announces Proposed Public Offering of Ordinary Shares and Pre-Funded WarrantsSeptember 24, 2024 4:01 PM Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares and Pre-Funded WarrantsSeptember 24, 2024 4:01 PM WAVE Life Sciences (WVE) PT Raised to $22 at H.C. WainwrightSeptember 24, 2024 11:32 AM Jones Trading Reiterates Buy Rating on WAVE Life Sciences (WVE)September 24, 2024 11:25 AM Form 8-K Wave Life Sciences Ltd. For: Sep 24September 24, 2024 7:35 AM WAVE Life Sciences (WVE) Announces Positive Interim Data from FORWARD-53 Trial of WVE-N531September 24, 2024 7:34 AM Wave Life Sciences Announces Positive Interim Data from FORWARD-53 Clinical Trial Evaluating WVE-N531 in Boys with Duchenne Muscular Dystrophy Amenable to Exon 53 SkippingSeptember 24, 2024 7:30 AM